Logo1
NNDC - 12th Annual Conference
Mr pencil

How would you like your name to appear on your certificate?



What activities did you attend at the event?
Agreement
By completing this form, you attest that you have participated in all selected activities in thier entirety.
CHES MEMBERS ONLY -- Please enter your CHES ID#
Only Florida licensees need to answer this question. Notice to Florida Licensees: In order for us to report your hours to CE Broker, you MUST provide us with your Florida alpha-numberic license number (e.g., CDCA.XXXXXX, LICDCII.XXXXXX, LCDCII.XXXXXX, LICDC.XXXXXX). Please be sure to enter this number accurately, or CE Broker will not record your hours. 
Only Ohio licensees need to answer this question. Notice to Ohio Licensees: In order for us to report your hours to CE Broker, you MUST provide us with your Ohio alpha-numeric license number (e.g., CDCA.XXXXXX, LICDCII.XXXXXX, LCDCII.XXXXXX, LICDC.XXXXXX). Please be sure to enter this number accurately, or CE Broker will not record your hours. 
(CPE Monitor) NABP e-Profile ID (ePID) - Example 123456:
(CPE Monitor) Date of Birth (MM/DD) - Example September 24 would be 0924:
Please rate the following:
The program was relevant to my work.
Content matched stated objectives.
Usefulness of handouts/AV/technology.
Quality of facilities and facility accommodations.
How well did the educational sessions give a balanced view of therapeutic options, including the use of generic names?
If you rated any of the above questions with 'fair,' 'poor,' 'disagree,' or 'strongly disagree' please explain in detail (e.g. session title, speaker name, situtation):
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
Objective 1: Gain new knowledge about the latest innovations in technology, translational clinical research, and treatment for depression and bipolar illnesses. Special emphasis is given this year to the COVDI-19 pandemic and the impacts it has had and will continue to have on research and care for mood disorders.s/government bodies with special interests in mental health care to educate, destigmatize, and enhance adherence and monitoring strategies.
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
The teaching methods used were appropriate to the objectives
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor used technology effectively
Understand the history mental health research following previous large scale disasters and current gaps in knowledge to reduce the impact of the COVID-19 pandemic.
The instructor used technology effectively
Those attending will be motivated to consider novel strategies to address scientific questions of interest to them during the need for social distancing.
ttendees will recognize common pitfalls in on-line research investigations
Participants will describe how to apply ResearchMatch and other on-line strategies to their research population.
Early stage investigators will appreciate how to utilize literature reviews to establish their knowledge in their research areas of interest.
The instructor used technology effectively
Attendees will understand the development of the field of telepsychiatry with emphasis on its application to mood disorders.
Attendees will learn about the impacts of COVID on telepsychiatry including administrative, regulatory and clinical aspects.
Attendees will explore the future implications of practice with telepsychiatry and technology during after the COVID emergency
The instructor used technology effectively
To list the major accomplishments of the WMD Task Group
To list the current and future priorities for the field of women and mood disorders
The instructor used technology effectively
Attendees will learn the value of systematic electronic capture of patient reported outcomes in the treatment of mood disorder.
Attendees will learn about typical symptom trajectories and expected course in treatment of depressed and bipolar patients participating at NNDC Mood Outcomes Program Sites.
Attendees will learn about some basic demographic and clinical correlates of suicidal ideation in patients participation in the NNDC Mood Outcomes Program Sites.
The instructor used technology effectively
To introduce the goals of the GenECT Study.
To describe the role of the NNDC in carrying out the GenECT Study and other related multi-site studies of severe and/or treatment resistant depression treated by ECT.
To provide an overview of the genetics of severe and/or treatment resistant depression treated by ECT.
The instructor used technology effectively
Understand the components of pharmacogenomic decision support tools marketed for psychiatry
Understand the current state of evidence for the efficacy of pharmacogenomic testing
Understand the similarities and differences between marketed pharmacogenomic decision support tools for depression
Understand the concerns raised about the published clinical trials of pharmacogenomic decision support tools.
The instructor used technology effectively
Define evaluation standards for mobile health apps
Understand mobile app use cases and implementation strategies
Evaluate reasons why patients and providers use mobile health apps
The instructor used technology effectively
Identify advantages and limitations of computer-assisted CBT for depression
Recognize evidence base for computer-assisted CBT for depression
Identify barriers and possible solutions for dissemination and implementation of computer-assisted CBT in clinical practice.
Please tell us about any sessions you found particularly good or bad.
Please tell us about any objectives you feel we accomplished well or poorly. 
Please tell us about any presenters you found particularly good or bad.
Please answer the following:
Do you believe this activity was appropriate for the scope of your professional activities?
Was the educational content scientifically sound?
If faculty spoke about off-label or investigational uses of a product, was that information disclosed to you?
Was the mode of education effective to learning?
If you answered "No" to any of the above questions, please explain.
Did you perceive any product/service/company/commercial bias in any educational session you attended or materials you received?
If you answered "Yes" to the above question, please detail the situation below (e.g. session title, speaker name):
Were you solicited by sales personnel in an educational room (other areas do not matter) while you attended this educational activity?
If you answered "Yes" to the above question, please explain in detail (e.g. who, when, where):
How much did you learn as a result of this education program?
What specifically did you learn during this activity that you intend to integrate into your practice?

What questions have arisen in your practice for which you need answers/strategies that you can implement?

What patient/client problems or patient/client challenges do you feel you are not able to address appropriately or to your satisfaction?
What problems are your patients/clients communicating to you that need attention or follow up?

Are you interested in basic, intermediate or advanced level trainings?

What barriers might you have that would interfere with implementation of new information learned from this training?

How can this training (the overall meeting) be improved to better impact competence, performance and/or patient/client outcomes?

Additional comments:

How did you attend this course?
Mr question
Provided by amedco